Delivery Order SPE2DB24D2100-SPE2DB25FBCAH
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals to the Defense Logistics Agency (DLA). The $1,793.26 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024, with a completion date of December 19, 2024. The award is part of a larger, $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $37,888.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 5, 2024 with a completion date of November 6, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals to the Defense Logistics Agency (DLA). The $20,408.39 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 27, 2024 with a completion date of December 30, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML to the Defense Logistics Agency (DLA). The contract, valued at $7,674.67, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $37,175.53 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 15, 2024, with an ultimate completion date of May 16, 2024. The award does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $9,399.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 28, 2023, with a completion date of November 29, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. The contract has a ceiling value of $1,521.95 and a period of performance through April 1, 2024. This award is associated with a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary vehicle for...
The federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,723.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a firm fixed price of $3,957.68. The contract is a delivery order with an ultimate completion date of September 6, 2024. This award does not have a set-aside designation, indicating open competition....
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which has been awarded a Delivery Order contract by the Defense Logistics Agency (DLA) Troop Support Medical with a ceiling value of $13,715.98. The contract has a firm fixed price pricing type and an ultimate completion date of July 30, 2024. This Delivery Order is likely...